Complete Filing Data
Apollo Global Management, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $42.52 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Apollo Global Management, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | $3.49B | $4.58B | $5.05B | -$1.96B | $1.84B | $157.0M |
| Revenues | $32.05B | $26.11B | $32.64B | $10.97B | $5.95B | $2.35B |
| Operating Expenses | $25.29B | $18.98B | $27.33B | $15.91B | $4.11B | $1.58B |
| Net Income Loss Attributable To Noncontrolling Interest | $1.91B | $1.80B | $1.46B | -$1.55B | $2.43B | $310.0M |
| Other Comprehensive Income Loss Tax | $835.0M | $21.0M | $513.0M | -$1.93B | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Of Tax | $3.34B | -$18.0M | $2.03B | -$7.49B | -$32.0M | $41.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax | $181.0M | -$101.0M | $65.0M | -$58.0M | -$32.0M | $42.0M |
| Other Comprehensive Income Loss Before Tax | $4.17B | $3.0M | $2.54B | -$9.42B | -$32.0M | $41.0M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax | $4.46B | -$1.12B | $5.28B | -$18.16B | $0.00 | -$1.0M |
| Net Income Loss Available To Common Stockholders Diluted | $3.40B | $4.48B | $5.00B | -$1.96B | $1.80B | $120.0M |
| Net Income Loss Available To Common Stockholders Basic | $3.40B | $4.48B | $5.00B | -$1.96B | $1.80B | $120.0M |
| Income Tax Expense Benefit | $1.28B | $1.06B | -$923.0M | -$739.0M | $594.0M | $86.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $6.68B | $7.44B | $5.59B | -$4.25B | $4.86B | $553.0M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $8.74B | $6.36B | $8.54B | -$11.00B | $4.24B | $508.0M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $2.40B | $1.70B | $1.73B | -$1.70B | $2.40B | $348.0M |
| Comprehensive Income Net Of Tax | $6.34B | $4.66B | $6.80B | -$9.29B | $1.84B | $160.0M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax | $252.0M | -$51.0M | -$199.0M | $4.0M | $0.00 | $0.00 |
| Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Redeemable Noncontrolling Interest | $5.40B | $6.37B | $6.47B | -$3.51B | $4.27B | |
| Income Taxes Paid | $590.0M | $1.05B | $358.0M | $1.01B | $121.0M | $37.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $1.74B | $630.0M | $442.0M | $811.0M | $853.0M | $1.43B | $682.0M | $599.0M | $1.01B | $640.0M | -$563.0M | -$1.64B | -$401.0M | $258.0M | $658.0M | $679.0M |
| Revenues | $9.82B | $6.81B | $5.55B | $7.77B | $6.02B | $7.04B | $2.60B | $13.70B | $5.30B | $4.84B | $2.98B | $2.29B | $862.0M | $1.08B | $1.38B | $2.30B |
| Operating Expenses | $7.07B | $5.72B | $4.34B | $5.82B | $4.58B | $4.89B | $1.75B | $12.83B | $3.57B | $3.65B | $4.02B | $5.45B | $2.78B | $648.0M | $747.0M | $1.02B |
| Net Income Loss Attributable To Noncontrolling Interest | $725.0M | $212.0M | $496.0M | $958.0M | $324.0M | $338.0M | -$42.0M | $151.0M | $528.0M | $367.0M | -$286.0M | -$969.0M | -$658.0M | $373.0M | $847.0M | $840.0M |
| Other Comprehensive Income Loss Tax | $356.0M | $266.0M | $273.0M | $682.0M | -$44.0M | -$4.0M | -$476.0M | $11.0M | $290.0M | -$727.0M | -$878.0M | -$615.0M | $0.00 | $0.00 | $0.00 | |
| Other Comprehensive Income Loss Net Of Tax | $1.37B | $1.11B | $1.10B | $2.72B | -$196.0M | -$67.0M | -$1.86B | -$124.0M | $1.22B | -$2.97B | -$3.63B | -$2.26B | -$9.0M | $4.0M | -$15.0M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax | -$40.0M | $163.0M | $63.0M | $61.0M | -$7.0M | -$32.0M | -$34.0M | $11.0M | $22.0M | -$21.0M | -$110.0M | -$9.0M | -$10.0M | $5.0M | -$16.0M | |
| Other Comprehensive Income Loss Before Tax | $1.73B | $1.38B | $1.37B | $3.40B | -$240.0M | -$71.0M | -$2.34B | -$113.0M | $1.51B | -$3.70B | -$4.51B | -$2.88B | -$9.0M | $4.0M | -$15.0M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax | $2.05B | $1.40B | $1.49B | $5.48B | -$979.0M | -$738.0M | -$3.16B | -$711.0M | $2.10B | -$5.92B | -$7.55B | -$6.70B | $1.0M | -$1.0M | $1.0M | |
| Net Income Loss Available To Common Stockholders Diluted | $1.71B | $605.0M | $418.0M | $787.0M | $828.0M | $1.40B | $660.0M | $599.0M | $1.01B | -$563.0M | -$1.64B | -$401.0M | $249.0M | $649.0M | $670.0M | |
| Net Income Loss Available To Common Stockholders Basic | $1.71B | $605.0M | $418.0M | $787.0M | $828.0M | $1.40B | $660.0M | $599.0M | $1.01B | -$563.0M | -$1.64B | -$401.0M | $249.0M | $649.0M | $670.0M | |
| Income Tax Expense Benefit | $438.0M | $3.0M | $243.0M | $317.0M | $261.0M | $422.0M | $243.0M | $201.0M | $253.0M | -$96.0M | -$381.0M | -$485.0M | $101.0M | $194.0M | $203.0M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.90B | $845.0M | $1.18B | $2.09B | $1.44B | $2.19B | $883.0M | $951.0M | $1.79B | -$945.0M | -$2.99B | -$1.54B | $732.0M | $1.70B | $1.72B | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $3.83B | $1.96B | $2.04B | $4.49B | $981.0M | $1.70B | -$1.22B | $626.0M | $2.76B | -$3.82B | -$6.24B | -$3.32B | $622.0M | $1.51B | $1.50B | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $897.0M | $435.0M | $684.0M | $1.33B | $308.0M | $336.0M | -$199.0M | $257.0M | $577.0M | -$479.0M | -$1.22B | -$603.0M | $364.0M | $851.0M | $826.0M | |
| Comprehensive Income Net Of Tax | $2.94B | $1.52B | $1.35B | $3.16B | $673.0M | $1.36B | -$1.02B | $369.0M | $2.18B | -$3.34B | -$5.02B | -$2.72B | $258.0M | $658.0M | $678.0M | |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax | $67.0M | -$8.0M | $229.0M | $221.0M | $84.0M | -$76.0M | -$213.0M | -$171.0M | $104.0M | -$80.0M | $81.0M | -$127.0M | $0.00 | $0.00 | $0.00 | |
| Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Redeemable Noncontrolling Interest | $2.46B | $842.0M | $938.0M | $1.77B | $1.18B | $1.77B | $637.0M | $715.0M | $1.54B | -$849.0M | -$2.61B | |||||
| Income Taxes Paid | $310.0M | $338.0M | $35.0M | $25.0M | $7.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $23.34B | $17.25B | $14.04B | $6.64B | $3.79B | $5.51B | $3.04B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $20.59B | $17.11B | $17.69B | $11.13B | $2.09B | $2.47B | $1.62B |
| Deferred Policy Acquisition Costs Deferred Sales Inducement Costs And Present Value Of Future Insurance Profits Net | $8.63B | $7.17B | $5.98B | $4.47B | $3.37B | ||
| Preferred Stock Dividends Income Statement Impact | $97.0M | $97.0M | $46.0M | $0.00 | $37.0M | $37.0M | |
| Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax | -$612.0M | $1.43B | -$2.24B | $8.43B | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.48B | -$579.0M | $6.56B | $9.04B | -$379.0M | $846.0M | |
| Gain Loss On Investments And Derivatives | $3.47B | $3.53B | $2.07B | -$5.74B | $3.17B | -$430.0M | |
| Restricted Cash And Cash Equivalents At Carrying Value | $1.35B | $946.0M | $1.76B | $1.68B | $708.0M | $18.0M | |
| Repayments Of Long Term Debt | $4.64B | $5.26B | $3.78B | $4.03B | $1.97B | $925.0M | |
| Policy Acquisition Costs Deferred | -$1.88B | -$1.51B | -$1.57B | -$1.13B | $0.00 | $0.00 | |
| Increase Decrease From Sale Of Investments | -$6.69B | -$4.71B | -$5.46B | -$4.00B | -$3.53B | -$2.08B | |
| Accretion Amortization Of Discounts And Premiums Investments | $202.0M | $123.0M | -$81.0M | -$285.0M | $0.00 | $0.00 | |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $16.0M | $12.0M | $1.03B | $1.77B | ||
| Retained Earnings Accumulated Deficit | $7.63B | $6.02B | $2.97B | -$1.01B | $1.14B | ||
| Minority Interest | $19.17B | $13.71B | $11.19B | $7.73B | $6.41B | ||
| Long Term Debt | $13.36B | $10.59B | $8.09B | $6.47B | $3.13B | ||
| Liabilities And Stockholders Equity | $460.95B | $377.90B | $313.49B | $257.22B | $30.50B | ||
| Liabilities | $418.43B | $346.92B | $288.24B | $241.82B | $18.54B | ||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Assets | $460.95B | $377.90B | $313.49B | $257.22B | $30.50B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.65B | -$5.49B | -$5.58B | -$7.34B | -$5.0M | ||
| Noncontrolling Interest Other Changes In Equity | $2.0M | -$13.0M | $250.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $23.14B | $19.32B | $17.98B | $17.86B | $15.27B | $14.79B | $8.44B | $8.23B | $8.07B | -$1.34B | $3.68B | $10.99B | $8.47B | $8.21B | $7.50B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $21.20B | $14.97B | $15.51B | $17.63B | $17.98B | $19.72B | $14.43B | $14.78B | $18.09B | $13.24B | $14.51B | $12.43B | $3.82B | $4.16B | $3.43B |
| Deferred Policy Acquisition Costs Deferred Sales Inducement Costs And Present Value Of Future Insurance Profits Net | $8.37B | $7.98B | $7.61B | $6.97B | $6.70B | $6.41B | $5.45B | $5.17B | $4.84B | $4.07B | $3.76B | $3.57B | |||
| Preferred Stock Dividends Income Statement Impact | $24.0M | $25.0M | $24.0M | $24.0M | $25.0M | $24.0M | $22.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.0M | $9.0M | $9.0M |
| Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax | -$235.0M | -$45.0M | -$528.0M | -$2.26B | $628.0M | $803.0M | $1.32B | $813.0M | -$802.0M | $2.37B | $2.90B | $3.56B | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.60B | $2.03B | $6.96B | $10.35B | $967.0M | ||||||||||
| Gain Loss On Investments And Derivatives | -$306.0M | $2.09B | $2.06B | -$1.67B | $635.0M | ||||||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $2.79B | $1.72B | $2.21B | $967.0M | $1.10B | $1.58B | $1.49B | $2.47B | $2.21B | $1.72B | $1.45B | $1.87B | $1.05B | $1.52B | $708.0M |
| Repayments Of Long Term Debt | $818.0M | $524.0M | $1.86B | $695.0M | $200.0M | ||||||||||
| Policy Acquisition Costs Deferred | -$515.0M | -$459.0M | -$375.0M | -$214.0M | $0.00 | ||||||||||
| Increase Decrease From Sale Of Investments | -$1.19B | -$879.0M | -$1.86B | -$1.81B | -$620.0M | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $42.0M | $5.0M | -$30.0M | -$73.0M | $0.00 | ||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $15.0M | $14.0M | $13.0M | $287.0M | $285.0M | $1.04B | $1.02B | $1.00B | $1.79B | |||
| Retained Earnings Accumulated Deficit | $7.31B | $5.92B | $5.63B | $4.87B | $4.38B | $3.86B | $535.0M | $153.0M | -$172.0M | -$2.84B | -$1.94B | -$93.0M | |||
| Minority Interest | $16.66B | $14.54B | $14.37B | $13.66B | $13.13B | $12.22B | $9.23B | $8.81B | $8.62B | $3.20B | $3.48B | $7.50B | |||
| Long Term Debt | $12.63B | $12.14B | $10.58B | $9.81B | $9.82B | $9.60B | $7.03B | $6.45B | $6.46B | $6.08B | $6.09B | $6.10B | |||
| Liabilities And Stockholders Equity | $449.54B | $419.55B | $395.05B | $368.69B | $346.50B | $334.05B | $283.24B | $281.98B | $270.32B | $250.34B | $247.85B | $261.56B | |||
| Liabilities | $409.75B | $385.69B | $362.70B | $337.15B | $318.09B | $307.04B | $265.27B | $264.66B | $252.59B | $247.45B | $239.69B | $241.28B | |||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Assets | $449.54B | $419.55B | $395.05B | $368.69B | $346.50B | $334.05B | $283.24B | $281.98B | $270.32B | $250.34B | $247.85B | $261.56B | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.49B | -$3.69B | -$4.58B | -$3.47B | -$5.82B | -$5.64B | -$8.10B | -$6.39B | -$6.16B | -$13.76B | -$9.79B | -$4.68B | |||
| Noncontrolling Interest Other Changes In Equity | -$26.0M | $9.0M | $5.0M | -$2.0M | -$2.0M | -$1.0M | $95.0M | $37.0M | $119.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Payments Of Dividends Common Stock | $1.20B | $1.09B | $1.01B | $962.0M | $517.0M | $550.0M |
| Net Cash Provided By Used In Operating Activities | $7.25B | $3.25B | $6.32B | $3.79B | $1.06B | -$1.62B |
| Net Cash Provided By Used In Investing Activities | -$63.97B | -$61.80B | -$42.41B | -$23.44B | -$1.55B | -$838.0M |
| Net Cash Provided By Used In Financing Activities | $60.20B | $57.97B | $42.64B | $28.71B | $109.0M | $3.30B |
| Increase Decrease In Other Operating Capital Net | $1.11B | $1.57B | $4.82B | -$3.38B | -$3.05B | $24.0M |
| Increase Decrease In Interest Sensitive Contract Liabilities | $7.68B | $5.68B | $3.92B | -$1.34B | $0.00 | $0.00 |
| Increase Decrease In Insurance Liabilities | -$367.0M | -$1.97B | $4.33B | $3.90B | $0.00 | $0.00 |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.0M | -$3.0M | $10.0M | -$15.0M | $0.00 | $0.00 |
| Depreciation Depletion And Amortization | $1.43B | $1.08B | $803.0M | $529.0M | $27.0M | $19.0M |
| Share Based Compensation | $789.0M | $721.0M | $1.03B | $540.0M | $1.18B | $213.0M |
| Proceeds From Sales Maturities And Repayments Of Investments And Distributions From Equity Method Investments | $92.61B | $59.43B | $29.05B | $34.30B | $4.03B | $1.82B |
| Proceeds From Payments For Other Financing Activities | -$178.0M | -$788.0M | $257.0M | $2.22B | -$187.0M | -$157.0M |
| Proceeds From Minority Shareholders | $2.93B | $3.13B | $2.86B | $4.82B | $2.28B | $843.0M |
| Proceeds From Issuance Of Long Term Debt | $7.22B | $7.95B | $4.91B | $5.75B | $1.33B | $4.30B |
| Proceeds From Annuities And Investment Certificates | $81.18B | $71.32B | $53.66B | $33.92B | $0.00 | $0.00 |
| Payments To Minority Shareholders | $1.93B | $1.30B | $766.0M | $1.05B | $1.50B | $855.0M |
| Payments To Acquire Investments And Contributions To Equity Method Investments | $9.20B | $3.84B | $4.65B | $3.99B | $0.00 | $0.00 |
| Payments For Repurchase Of Common Stock | $773.0M | $890.0M | $561.0M | $635.0M | $299.0M | $92.0M |
| Payments For Proceeds From Other Investing Activities | $1.69B | $1.19B | -$231.0M | $277.0M | $69.0M | $52.0M |
| Payments For Proceeds From Derivative Instrument Financing Activities | -$340.0M | -$4.12B | -$829.0M | $330.0M | $0.00 | $0.00 |
| Increase Decrease In Trading Securities | $6.89B | $5.59B | $5.74B | $7.14B | $4.73B | $4.99B |
| Increase Decrease In Consolidation Operating Activities | $42.0M | -$248.0M | $54.0M | $482.0M | $48.0M | -$502.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Payments Of Dividends Common Stock | $278.0M | $259.0M | $241.0M | $229.0M | $229.0M | $124.0M | $122.0M | $116.0M | $144.0M |
| Net Cash Provided By Used In Operating Activities | $1.01B | $70.0M | $1.07B | -$3.99B | -$229.0M | ||||
| Net Cash Provided By Used In Investing Activities | -$16.89B | -$16.39B | -$5.64B | $3.10B | $19.0M | ||||
| Net Cash Provided By Used In Financing Activities | $14.27B | $18.34B | $11.52B | $11.24B | $1.18B | ||||
| Increase Decrease In Other Operating Capital Net | $589.0M | $39.0M | $852.0M | -$2.19B | -$1.33B | ||||
| Increase Decrease In Interest Sensitive Contract Liabilities | $519.0M | $2.13B | $2.23B | -$548.0M | $0.00 | ||||
| Increase Decrease In Insurance Liabilities | -$289.0M | -$671.0M | $64.0M | -$776.0M | $0.00 | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.0M | -$2.0M | $3.0M | -$4.0M | $0.00 | ||||
| Depreciation Depletion And Amortization | $308.0M | $238.0M | $165.0M | $106.0M | $6.0M | ||||
| Share Based Compensation | $149.0M | $189.0M | $140.0M | $168.0M | $56.0M | ||||
| Proceeds From Sales Maturities And Repayments Of Investments And Distributions From Equity Method Investments | $18.98B | $9.60B | $6.33B | $13.56B | $873.0M | ||||
| Proceeds From Payments For Other Financing Activities | -$763.0M | -$742.0M | -$345.0M | -$139.0M | -$50.0M | ||||
| Proceeds From Minority Shareholders | $607.0M | $1.00B | $617.0M | $3.38B | $821.0M | ||||
| Proceeds From Issuance Of Long Term Debt | $294.0M | $2.83B | $1.20B | $3.66B | $257.0M | ||||
| Proceeds From Annuities And Investment Certificates | $25.31B | $20.80B | $12.01B | $8.34B | $0.00 | ||||
| Payments To Minority Shareholders | $210.0M | $305.0M | $183.0M | $633.0M | $160.0M | ||||
| Payments To Acquire Investments And Contributions To Equity Method Investments | $1.34B | $634.0M | $1.40B | $135.0M | $848.0M | ||||
| Payments For Repurchase Of Common Stock | $193.0M | $260.0M | $458.0M | $226.0M | $0.00 | ||||
| Payments For Proceeds From Other Investing Activities | -$902.0M | -$295.0M | -$459.0M | $935.0M | $6.0M | ||||
| Payments For Proceeds From Derivative Instrument Financing Activities | $4.40B | -$611.0M | -$3.49B | -$27.0M | $0.00 | ||||
| Increase Decrease In Trading Securities | $871.0M | $1.52B | $1.21B | $6.03B | $1.62B | ||||
| Increase Decrease In Consolidation Operating Activities | $23.0M | $0.00 | $51.0M | $946.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $5.54 | $7.33 | $8.28 | $-3.43 | $7.32 | $0.44 |
| Earnings Per Share Basic | $5.58 | $7.39 | $8.32 | $-3.43 | $7.32 | $0.44 |
| Weighted Average Number Of Shares Outstanding Basic | 589.5M | 586.1M | 581.4M | 584.7M | 236.6M | 227.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 593.7M | 604.0M | 588.8M | 584.7M | 236.6M | 227.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $2.78 | $0.99 | $0.68 | $1.29 | $1.35 | $2.28 | $1.10 | $1.00 | $1.66 | $-0.98 | $-2.82 | $-0.70 | $1.01 | $2.70 | $2.81 |
| Earnings Per Share Basic | $2.82 | $1.00 | $0.68 | $1.30 | $1.36 | $2.31 | $1.10 | $1.00 | $1.67 | $-0.98 | $-2.82 | $-0.70 | $1.01 | $2.70 | $2.81 |
| Weighted Average Number Of Shares Outstanding Basic | 589.4M | 586.7M | 587.3M | 585.4M | 587.1M | 588.1M | 578.8M | 579.0M | 584.1M | 584.3M | 584.8M | 586.5M | 239.5M | 231.1M | 230.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 607.8M | 590.4M | 593.0M | 588.5M | 590.2M | 605.4M | 578.8M | 579.0M | 584.2M | 584.3M | 584.8M | 586.5M | 239.5M | 231.1M | 230.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Noncontrolling Interest Increase From Business Combination | $2.96B | $3.14B | $2.86B | $4.82B | $2.28B | $843.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $710.0M | $649.0M | $947.0M | $462.0M | $1.15B | $174.0M |
| Stock Repurchased During Period Value | $773.0M | $894.0M | $563.0M | $635.0M | $299.0M | $92.0M |
| Adjustment To Additional Paid In Capital Accretion Of Redeemable Noncontrolling Interests | $5.0M | -$3.0M | -$15.0M | -$67.0M | -$70.0M | |
| Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Before Tax | -$103.0M | -$149.0M | -$374.0M | $366.0M | $0.00 | |
| Repayments Of Annuities And Investment Certificates | $22.66B | $19.12B | $14.13B | $10.21B | $0.00 | $0.00 |
| Other Noncash Income Expense | -$593.0M | -$92.0M | $415.0M | -$321.0M | -$642.0M | -$77.0M |
| Investment Income Net | $1.37B | $1.36B | $1.14B | $1.31B | $3.70B | $392.0M |
| Interest Paid Net | $994.0M | $805.0M | $720.0M | $566.0M | $556.0M | $307.0M |
| Additional Paid In Capital | $16.95B | $15.33B | $15.25B | $14.98B | $2.10B | |
| Stock Issued During Period Value New Issues | $84.0M | $1.40B | $252.0M | $22.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noncontrolling Interest Increase From Business Combination | $1.00B | $579.0M | $636.0M | $479.0M | $996.0M | $1.01B | $1.04B | $112.0M | $617.0M | $278.0M | $665.0M | $3.01B | $177.0M | $191.0M | $821.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $193.0M | $145.0M | $128.0M | $126.0M | $136.0M | $163.0M | $119.0M | $123.0M | $122.0M | $100.0M | $117.0M | $141.0M | $46.0M | $41.0M | $45.0M |
| Stock Repurchased During Period Value | $340.0M | $193.0M | $457.0M | $75.0M | $260.0M | $78.0M | $460.0M | $26.0M | $211.0M | $226.0M | $78.0M | $123.0M | |||
| Adjustment To Additional Paid In Capital Accretion Of Redeemable Noncontrolling Interests | $5.0M | -$1.0M | -$1.0M | -$2.0M | -$6.0M | -$10.0M | -$11.0M | -$28.0M | -$20.0M | -$7.0M | -$16.0M | -$27.0M | |||
| Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Before Tax | -$113.0M | -$135.0M | $116.0M | -$93.0M | $34.0M | -$28.0M | -$254.0M | -$55.0M | $89.0M | -$52.0M | $179.0M | $397.0M | |||
| Repayments Of Annuities And Investment Certificates | $5.25B | $4.79B | $2.71B | $2.25B | $0.00 | ||||||||||
| Other Noncash Income Expense | -$300.0M | -$72.0M | -$66.0M | -$42.0M | $0.00 | ||||||||||
| Investment Income Net | $370.0M | $416.0M | $474.0M | $478.0M | $1.50B | ||||||||||
| Interest Paid Net | $321.0M | $167.0M | $169.0M | $203.0M | $95.0M | ||||||||||
| Additional Paid In Capital | $16.93B | $15.70B | $15.53B | $15.07B | $15.32B | $15.17B | $14.61B | $14.47B | $14.41B | $15.26B | $15.41B | $15.76B | |||
| Stock Issued During Period Value New Issues | $84.0M | $1.40B | $231.0M | $21.0M | $22.0M |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.